Sar in the alkoxy lactone series:: The discovery of DFP, a potent and orally active COX-2 inhibitor

被引：49

作者：

Leblanc, Y

Roy, P

Boyce, S

Brideau, C

Chan, CC

Charleson, S

Gordon, R

Grimm, E

Guay, J

Léger, S

Li, CS

Riendeau, D

Visco, D

Wang, Z

Webb, J

Xu, LJ

Prasit, P

机构：

[1] Merck Frosst Ctr Therapeut Res, Pointe Claire, PQ H9R 4P8, Canada

[2] Merck Res Labs, Harlow, Essex, England

[3] Merck Res Labs, Rahway, NJ USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1999年 / 9卷 / 15期

关键词：

D O I：

10.1016/S0960-894X(99)00365-0

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Extensive SAR has been established in the alkoxy lactone series and this has lead to the discovery of DFP (5,5-dimethyl-3-(2-propoxy)-4-methanesulfonylphenyl)-2-(5H)-furanone), a potent COX-2 inhibitor exhibiting in vivo efficacy in all models studied. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.

引用

页码：2207 / 2212

页数：6

共 50 条

[31] Novel 1,2-diarylcyclobutenes: Selective and orally active COX-2 inhibitors
Friesen, RW
Dube, D
Fortin, R
Frenette, R
Prescott, S
Cromlish, W
Greig, GM
Kargman, S
Wong, E
Chan, CC
Gordon, R
Xu, LJ
Riendeau, D
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (22) : 2677 - 2682
[32] Synthesis and SAR of 2-aryloxy-4-alkoxy-pyridines as potent orally active corticotropin-releasing factor 1 receptor antagonists
Chen, Yuhpyng L.
Braselton, John
Forman, James
Gallaschun, Randall J.
Mansbach, Robert
Schmidt, Anne W.
Seeger, Thomas F.
Sprouse, Jeff S.
Tingley, F. David, III
Winston, Elizabeth
Schulz, David W.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (05) : 1377 - 1384
[33] Discovery of a novel, potent and orally active series of γ-lactams as selective NK1 antagonists
Paliwal, Sunil
Reichard, Gregory A.
Shah, Sapna
Wrobleski, Michelle Laci
Wang, Cheng
Stengone, Carmine
Tsui, Hon-Chung
Xiao, Dong
Duffy, Ruth A.
Lachowicz, Jean E.
Nomeir, Amin A.
Varty, Geoffrey B.
Shih, Neng-Yang
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 4168 - 4171
[34] Discovery of UR-8880:: A new COX-2 selective inhibitor.
Almansa, C
Alfon, J
Cavalcanti, FL
Escamilla, I
Gómez, L
Miralles, A
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U686 - U686
[35] In vitro and in vivo profile of 2-(3-di-fluoromethyl-5-phenylpyrazol-1-yl)-5-methanesulfonylpyridine, a potent, selective, and orally active canine COX-2 inhibitor
Li, J
Lynch, MP
DeMello, KL
Sakya, SM
Cheng, HM
Rafka, RJ
Bronk, BS
Jaynes, BH
Kilroy, C
Mann, DW
Haven, ML
Kolosko, NL
Petras, C
Seibel, SB
Lund, LA
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (05) : 1805 - 1809
[36] Ex vivo assays demonstrate potency and selectivity of the COX-2 inhibitor DFP after single dose administration
A. Dallob
I. De Lepeleire
A. Van Hecken
A. Porras
M. Depré
S. Mukhopadhyay
M. Flynn
L. Wildonger
K. Gottesdiener
W. Tanaka
P. De Schepper
Inflammation Research, 1999, 48 (Suppl 2) : 130 - 131
[37] Ex vivo assays demonstrate potency and selectivity of the COX-2 inhibitor DFP after single dose administration
Dallob, A
De Lepeleire, I
Van Hecken, A
Porras, A
Depré, M
Mukhopadhyay, S
Flynn, M
Wildonger, L
Gottesdiener, K
Tanaka, W
De Schepper, P
INFLAMMATION RESEARCH, 1999, 48 : S130 - S131
[38] An efficient asymmetric synthesis of a potent COX-2 inhibitor L-784,512
Tan, LS
Chen, CY
Larsen, RD
Verhoeven, TR
Reider, PJ
TETRAHEDRON LETTERS, 1998, 39 (23) : 3961 - 3964
[39] An Efficient Asymmetric Synthesis of A Potent COX-2 Inhibitor L-784,512
Tan, L.
Chen, C.-Y.
Larsen, R. D.
Verhoeven, T. R.
Tetrahedron Letters, 39 (23):
[40] Biphenylsulfonamide endothelin a receptor antagonists: Discovery and SAR of potent, selective and orally active second generation antagonists.
Murugesan, N
Gu, ZX
Spergel, S
Young, M
Chen, P
Liu, ECK
Zhang, RG
Marino, A
Morrison, RA
Webb, ML
Moreland, S
Barrish, JC
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A108 - A108

← 1 2 3 4 5 →